Zobrazeno 1 - 10
of 26
pro vyhledávání: ''
Autor:
Jeffrey E. Gershenwald, Charles R. Scoggins, Kelly M. McMasters, Peter D. Beitsch, B. Scott Davidson, Douglas S. Reintgen, Michael J. Edwards, Arnold J. Stromberg, James S. Goydos, Michael E. Egger, Marshall M. Urist, Stephan Ariyan, Jeffrey J. Sussman, Merrick I. Ross, Lee Hagendoorn, Robert C.G. Martin, R. Dirk Noyes
Publikováno v:
Journal of Clinical Oncology. 34:1079-1086
Purpose The Sunbelt Melanoma Trial is a prospective randomized trial evaluating the role of high-dose interferon alfa-2b therapy (HDI) or completion lymph node dissection (CLND) for patients with melanoma staged by sentinel lymph node (SLN) biopsy. P
Autor:
T. Andrew Lister, Lawrence H. Schwartz, Sally F. Barrington, Bruce D. Cheson, Franco Cavalli, Richard I. Fisher, Emanuele Zucca
Publikováno v:
Cheson, B D, Fisher, R I, Barrington, S F, Cavalli, F, Schwartz, L H, Lister, T A 2014, ' Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma : the Lugano classification ', Journal of Clinical Oncology, vol. 32, no. 27, pp. 3059-3068 . https://doi.org/10.1200/JCO.2013.54.8800
The purpose of this work was to modernize recommendations for evaluation, staging, and response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). A workshop was held at the 11th International Conference on Malignant Ly
Autor:
Gary K. Schwartz, William D. Tap
Publikováno v:
Journal of Clinical Oncology. 32:1543-1546
Autor:
Igor Puzanov, Rodney J. Hicks, Ravi K. Amaravadi, K. B. Nolop, Paul B. Chapman, Grant A. McArthur, Antoni Ribas, Jason Callahan, Keith T. Flaherty, Richard J. Lee, Kevin B. Kim, Jeffrey A. Sosman
Publikováno v:
Journal of Clinical Oncology. 30:1628-1634
Purpose Imaging with [18F]fluorodeoxyglucose (FDG) –positron emission tomography (PET) allows early recognition of a response to agents that target key driver mutations in human cancer. We aimed to determine the metabolic response rate to vemurafen
Autor:
Gabriel N. Hortobagyi, Yun Gong, Naoki Niikura, Shana L. Palla, Yutaka Tokuda, Elizabeth A. Mittendorf, Ana M. Gonzalez-Angulo, Naoki Hayashi, Naoto T. Ueno, Jun Liu
Publikováno v:
Journal of Clinical Oncology. 30:593-599
Purpose We evaluated whether patients with human epidermal growth factor receptor 2 (HER2) –positive primary breast tumors had metastatic tumors that were HER2 positive (concordant) or HER2 negative (discordant). We then evaluated whether treatment
Autor:
Tanja Pelz, Philipp A. Schnabel, Michael Thomas, Thomas Kuhnt, Esther Herpel, Gerhard Dyckhoff, Sandra Gottschling, Roland Penzel
Publikováno v:
Journal of Clinical Oncology. 29:e616-e619
Autor:
Keun Seok Lee, Han Sung Kang, Byoung-Ho Nam, Seeyoun Lee, In Hae Park, Jungsil Ro, Seok Won Kim, So-Youn Jung, Eun-A Kim, Youngmee Kwon
Publikováno v:
Journal of Clinical Oncology. 28:2705-2711
Purpose Goserelin and letrozole in premenopausal patients can result in clinical outcomes comparable to those obtained by letrozole alone in postmenopausal patients with metastatic breast cancer (MBC). Patients and Methods A total of 73 patients with
Autor:
David J. Straus, Daniel A. Filippa, Camelia Sima, Julie Teruya-Feldstein, James F. Caravelli, Carol S. Portlock, Heiko Schöder, Sarah A. Weaver, Alexia Iasonos, Ariela Noy, Steven M. Horwitz, Andrew D. Zelenetz, Craig H. Moskowitz, Owen A. O'Connor, Maria Lia Palomba, Jessica Meikle, Paul A. Hamlin
Publikováno v:
Journal of Clinical Oncology. 28:1896-1903
Purpose In studies of diffuse large B-cell lymphoma, positron emission tomography with [18F]fluorodeoxyglucose (FDG-PET) performed after two to four cycles of chemotherapy has demonstrated prognostic significance. However, some patients treated with
Autor:
Michel Toubeau, Gilles Calais, Max Lonneux, Marc Hamoir, Laurence Digue, B. Bridji, Philippe Maingon, Vincent Grégoire, Hervé Reychler, Christian Duvillard
Publikováno v:
Journal of Clinical Oncology. 28:1190-1195
Purpose To address the impact of positron emission tomography with [18F]fluorodeoxyglucose (PET-FDG) on the initial staging and management of patients with head and neck squamous cell carcinoma (HNSCC). Patients and Methods This multicenter, prospect
Publikováno v:
Journal of Clinical Oncology. 28:556-561
Purpose Older patients with acute myeloid leukemia (AML) have limited treatment options because of the lack of effectiveness and the toxicity of available therapies. We investigated the efficacy and toxicity of the hypomethylating agent decitabine as